{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:11:31Z","timestamp":1785222691466,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","nmd-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.nmd.2025.105281","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T21:47:59Z","timestamp":1738273679000},"page":"105281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Motor function testing rates and outcomes in Duchenne muscular dystrophy with comorbid autism and attention-deficit\/hyperactivity disorder"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3399-5043","authenticated-orcid":false,"given":"Dennis","family":"Keselman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Glanzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Y.","family":"Thelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Prosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Matesanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2025.105281_bib0001","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.nmd.2025.105281_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.nmd.2025.105281_bib0003","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.nmd.2025.105281_bib0004","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2025.105281_bib0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/348725a0","article-title":"Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons","volume":"348","author":"Lidov","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2025.105281_bib0006","doi-asserted-by":"crossref","first-page":"e1597","DOI":"10.1212\/WNL.0000000000008363","article-title":"Relationships between DMD mutations and neurodevelopment in dystrophinopathy","volume":"93","author":"Thangarajh","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105281_bib0007","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0960-8966(94)90072-8","article-title":"Cognitive impairment in Duchenne muscular dystrophy","volume":"4","author":"Bresolin","year":"1994","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105281_bib0008","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/08830738050200100201","article-title":"Association of Duchenne muscular dystrophy with autism spectrum disorder","volume":"20","author":"Wu","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0009","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073807309775","article-title":"Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive\u2013compulsive disorder","volume":"23","author":"Hendriksen","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0010","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.apmr.2022.05.015","article-title":"Prevalence of neuropsychiatric disorders in Duchenne and Becker muscular dystrophies: a systematic review and meta-analysis","volume":"103","author":"Pascual-Morena","year":"2022","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2025.105281_bib0011","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/DBP.0000000000000177","article-title":"Neurobehavioral concerns among males with dystrophinopathy using population-based surveillance data from the Muscular Dystrophy Surveillance, Tracking, and Research network","volume":"36","author":"Caspers Conway","year":"2015","journal-title":"J Dev Behav Pediatr JDBP"},{"key":"10.1016\/j.nmd.2025.105281_bib0012","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/acn3.51914","article-title":"Association between neurodevelopmental impairments and motor function in Duchenne muscular dystrophy","volume":"10","author":"Thangarajh","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0013","article-title":"Neurodevelopmental needs in young boys with Duchenne muscular dystrophy (DMD): observations from the Cooperative International Neuromuscular Research Group (CINRG) DMD Natural History Study (DNHS)","volume":"10","author":"Thangarajh","year":"2018","journal-title":"PLoS Curr"},{"key":"10.1016\/j.nmd.2025.105281_bib0014","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/jcsm.12914","article-title":"Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy","volume":"13","author":"Chesshyre","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nmd.2025.105281_bib0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/hipo.23015","article-title":"The expression of the distal dystrophin isoforms Dp140 and Dp71 in the human epileptic hippocampus in relation to cognitive functioning","volume":"29","author":"Hoogland","year":"2019","journal-title":"Hippocampus"},{"key":"10.1016\/j.nmd.2025.105281_bib0016","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tins.2012.04.004","article-title":"The dystrophin-glycoprotein complex in brain development and disease","volume":"35","author":"Waite","year":"2012","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.nmd.2025.105281_bib0017","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/WNL.55.4.559","article-title":"Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy","volume":"55","author":"Felisari","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105281_bib0018","doi-asserted-by":"crossref","first-page":"e8803","DOI":"10.1371\/journal.pone.0008803","article-title":"Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy","volume":"5","author":"Taylor","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.nmd.2025.105281_bib0019","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1093\/hmg\/ddp320","article-title":"Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression","volume":"18","author":"Daoud","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2025.105281_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/dmcn.12922","article-title":"Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations","volume":"58","author":"Ricotti","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0021","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s10803-010-0981-3","article-title":"Motor coordination in autism spectrum disorders: a synthesis and meta-analysis","volume":"40","author":"Fournier","year":"2010","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.nmd.2025.105281_bib0022","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2522\/ptj.20100294","article-title":"Current perspectives on motor functioning in infants, children, and adults with autism spectrum disorders","volume":"91","author":"Bhat","year":"2011","journal-title":"Phys Ther"},{"key":"10.1016\/j.nmd.2025.105281_bib0023","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/aur.2230","article-title":"Prevalence of motor difficulties in Autism spectrum disorder: analysis of a population-based cohort","volume":"13","author":"Licari","year":"2020","journal-title":"Autism Res Off J Int Soc Autism Res"},{"key":"10.1016\/j.nmd.2025.105281_bib0024","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/WCO.0000000000000541","article-title":"Motor development and delay: advances in assessment of motor skills in autism spectrum disorders","volume":"31","author":"Wilson","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0025","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/19411243.2019.1604286","article-title":"The effects of motor and cognitive impairments on daily living activities and quality of life in children with autism","volume":"12","author":"G\u00fcnal","year":"2019","journal-title":"J Occup Ther Sch Early Interv"},{"key":"10.1016\/j.nmd.2025.105281_bib0026","series-title":"The national commission for the protection of human subjects of biomedical and behavioral research","year":"1979"},{"key":"10.1016\/j.nmd.2025.105281_bib0027","unstructured":"Camacho P. CHOP Center for Rehabilitation Research Registry Version 1.4. Arcus at Children's Hospital of Philadelphia n.d."},{"key":"10.1016\/j.nmd.2025.105281_bib0028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2377-12-91","article-title":"Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures","volume":"12","author":"Lerario","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0029","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nmd.2009.06.368","article-title":"Reliability of the North Star Ambulatory Assessment in a multicentric setting","volume":"19","author":"Mazzone","year":"2009","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.nmd.2025.105281_bib0030","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/dmcn.12213","article-title":"Development of the Performance of the Upper limb module for Duchenne muscular dystrophy","volume":"55","author":"Mayhew","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239064","article-title":"Test-retest reliability of the Performance of Upper Limb (PUL) module for muscular dystrophy patients","volume":"15","author":"Gandolla","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2025.105281_bib0032","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.nmd.2013.11.014","article-title":"Reliability of the performance of upper limb assessment in Duchenne muscular dystrophy","volume":"24","author":"Pane","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105281_bib0033","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/mus.26161","article-title":"Longitudinal timed function tests in Duchenne muscular dystrophy: imagingDMD cohort natural history","volume":"58","author":"Arora","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105281_bib0034","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mus.26334","article-title":"Timed function tests have withstood the test of time as clinically meaningful and responsive endpoints in duchenne muscular dystrophy","volume":"58","author":"McDonald","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105281_bib0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.nmd.2025.105281_bib0036","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/dmcn.15176","article-title":"Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy","volume":"64","author":"Zambon","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0037","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nmd.2023.11.011","article-title":"Gain and loss of upper limb abilities in duchenne muscular dystrophy patients: a 24-month study","volume":"34","author":"Coratti","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105281_bib0038","doi-asserted-by":"crossref","unstructured":"Chesshyre M., Ridout D., Hashimoto Y., Ookubo Y., Torelli S., Maresh K., et al. Duchenne muscular dystrophy patients lacking the dystrophin isoforms Dp140 and Dp71 and mouse models lacking Dp140 have a more severe motor phenotype 2021:2021.07.27.21261120. https:\/\/doi.org\/10.1101\/2021.07.27.21261120.","DOI":"10.1101\/2021.07.27.21261120"},{"key":"10.1016\/j.nmd.2025.105281_bib0039","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: one gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0040","doi-asserted-by":"crossref","first-page":"12575","DOI":"10.1038\/s41598-017-12981-5","article-title":"Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy","volume":"7","author":"Doorenweerd","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2025.105281_bib0041","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.24222","article-title":"Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy","volume":"76","author":"Doorenweerd","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0042","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1097\/DBP.0000000000001105","article-title":"The hidden disease: delayed diagnosis in duchenne muscular dystrophy and Co-occurring conditions","volume":"43","author":"Lee","year":"2022","journal-title":"J Dev Behav Pediatr JDBP"},{"key":"10.1016\/j.nmd.2025.105281_bib0043","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ana.26755","article-title":"Delandistrogene Moxeparvovec gene therapy in ambulatory patients (Aged \u22654 to <8\u2009Years) with Duchenne muscular dystrophy: 1-year interim results from study SRP-9001-103 (ENDEAVOR)","volume":"94","author":"Zaidman","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0044","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1474-4422(24)00036-X","article-title":"Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"23","author":"Mercuri","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0045","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1212\/WNL.0000000000203455","article-title":"EMBARK, a phase 3 trial evaluating safety and efficacy of Delandistrogene Moxeparvovec (SRP- 9001) in Duchenne muscular dystrophy (DMD): study design and baseline characteristics (P5-8.012)","volume":"100","author":"Muntoni","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105281_bib0046","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/nat.2021.0043","article-title":"Long-term safety and efficacy data of Golodirsen in ambulatory patients with Duchenne muscular dystrophy amenable to exon 53 skipping: a first-in-human, multicenter, two-part, open-label, phase 1\/2 trial","volume":"32","author":"Servais","year":"2022","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.nmd.2025.105281_bib0047","article-title":"Phase 2 multiple-ascending-dose study of SRP-5051 PPMO in patients with DMD amenable to exon 51 skipping: part A results","author":"Campbell","year":"2024","journal-title":"Abstr MDA Clin Sci Conf"},{"key":"10.1016\/j.nmd.2025.105281_bib0048","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1212\/WNL.0000000000206199","article-title":"Effects of EDG-5506, a fast myosin modulator, on function and biomarkers of muscle damage in adults with Becker muscular dystrophy (S21.002)","volume":"102","author":"Phan","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105281_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294847","article-title":"A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory duchenne muscular dystrophy and pharmacology in mdx mice","volume":"19","author":"Woodcock","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.nmd.2025.105281_bib0050","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.nmd.2022.07.248","article-title":"Casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: interim results from the phase 3 ESSENCE trial","volume":"32","author":"Iannaccone","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105281_bib0051","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.nmd.2023.07.026","article-title":"A phase 1\/2 study of DYNE-251 in males with DMD mutations amenable to exon 51 skipping: DELIVER study design","volume":"33","author":"Naylor","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105281_bib0052","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.nmd.2022.07.234","article-title":"FP.28 IGNITE DMD phase I\/II study of SGT-001 microdystrophin gene therapy for DMD: long-term outcomes and expression update","volume":"32","author":"Dreghici","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105281_bib0053","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.nmd.2023.07.155","article-title":"The antisense oligonucleotide BMN 351 durably ameliorates dystrophic phenotypes in a mouse model of exon 51\u2013skip-amenable Duchenne muscular dystrophy","volume":"33","author":"Porco","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105281_bib0054","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1212\/WNL.0000000000204511","article-title":"Phase 1\/2 trial evaluating AOC 1044 in healthy volunteers and participants with DMD mutations amenable to exon 44 skipping (DMD44): EXPLORE44 trial design (P4-8.007)","volume":"102","author":"Stahl","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105281_bib0055","first-page":"17","article-title":"Mood and cognitive changes during systemic corticosteroid therapy","volume":"3","author":"Brown","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.nmd.2025.105281_bib0056","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.mayocp.2014.01.010","article-title":"Psychiatric adverse effects of pediatric corticosteroid use","volume":"89","author":"Drozdowicz","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nmd.2025.105281_bib0057","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4065\/81.10.1361","article-title":"Psychiatric adverse effects of corticosteroids","volume":"81","author":"Warrington","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nmd.2025.105281_bib0058","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2025.105281_bib0059","first-page":"9","article-title":"Pharmacokinetics and metabolism of deflazacort in the rat, dog, monkey and man","volume":"171","author":"Assandri","year":"1984","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.nmd.2025.105281_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-016-0111-8","article-title":"Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids","volume":"18","author":"Parente","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.nmd.2025.105281_bib0061","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0014-2999(81)90115-1","article-title":"Differential binding in vitro to glucocorticoid receptors of deflazacort and prednisolone","volume":"76","author":"Luzzani","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nmd.2025.105281_bib0062","first-page":"8","article-title":"Prednisone and deflazacort in duchenne muscular dystrophy: do they play a different role in child behavior and perceived quality of life?","author":"Sienko","year":"2016","journal-title":"PLoS Curr"},{"key":"10.1016\/j.nmd.2025.105281_bib0063","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1212\/WNL.0000000000003217","article-title":"Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy","volume":"87","author":"Griggs","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105281_bib0064","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JND-210743","article-title":"Stride velocity 95th centile: insights into gaining regulatory qualification of the first wearable-derived digital endpoint for use in Duchenne muscular dystrophy trials","volume":"9","author":"Servais","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105281_bib0065","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3233\/JND-230188","article-title":"Stride velocity 95th centile detects decline in ambulatory function over shorter intervals than the 6-minute walk test or north star ambulatory assessment in Duchenne muscular dystrophy","volume":"11","author":"Rabbia","year":"2024","journal-title":"J Neuromuscul Dis"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T05:00:05Z","timestamp":1741928405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":65,"alternative-id":["S0960896625000082"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105281","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Motor function testing rates and outcomes in Duchenne muscular dystrophy with comorbid autism and attention-deficit\/hyperactivity disorder","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105281"}}